Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 101 - 120 of 493 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
  • Melanoma
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Solid Tumors
A Phase Ib Study of Tremelimumab and MEDI4736 in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 13-197]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Phase I Study of Nivolumab with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189]
Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of MEDI4736 in Patients with Stage IIIB-IV Non-Small Cell Lung Cancer Containing the PD-L1 Protein
[Protocol 14-103]
Rizvi, Naiyer
  • Lung Cancer, Non-Small Cell
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037]
Rizk, Nabil
  • Esophageal Disorders
    • Barrett's Esophagus
  • Upper Gastrointestinal
    • Esophageal Cancer
A Study to See if Mesothelin Can Serve as a Marker of Early Lung Cancer
Newly Diagnosed
[Protocol 13-262]
Rizk, Nabil
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Study Assessing the Predictive Value of Tumor Hypoxia (Low Oxygen Supply) in Patients with Non-Small Cell Lung Cancer
[Protocol 13-186]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase I Study of Stereotactic Body Radiation Therapy for Inoperable Locally Advanced Non-Small Cell Lung Cancer
Newly Diagnosed
[Protocol 13-113]
Rimner, Andreas
  • Lung Cancer, Non-Small Cell
Calypso-Based Deep Inspiration Breath Hold Radiation Treatment for Lung Cancer
[Protocol 13-174]
Rimner, Andreas
  • Lung Cancer
A Phase I/II Study of Crizotinib and Ganetespib (STA-9090) in ALK-Positive Lung Cancers
[Protocol 12-015]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
[Protocol 12-113]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase I Study of EGF816 in Patients with Lung Cancer Containing the EGFR T790M Mutation
[Protocol 14-112]
Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase II Study of Temozolomide Alone and with Capecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors
[Protocol 13-194]
Reidy-Lagunes, Diane
  • Upper Gastrointestinal
    • Neuroendocrine
    • Pancreatic Cancer
A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer
[Protocol 11-182]
Rathkopf, Dana
  • Prostate Cancer
    • Localized Disease
A Phase II Study of MLN0128 in Men with Castration-Resistant Prostate Cancer
[Protocol 13-143]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase III Study of ARN-509 versus Placebo in Men with Non-Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-243]
Rathkopf, Dana
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase IA/B Study of CC-115 in Castration-Resistant Prostate Cancer
[Protocol 12-080]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase Ib Study of ARN-509 plus Everolimus in Men with Progressive Metastatic Castration-Resistant Prostate Cancer After Abiraterone Therapy
[Protocol 13-025]
Rathkopf, Dana
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy